Prescription Hair Loss and Hair Removal Drugs Market
The market for prescription hair loss and hair removal drugs is expanding day by day as changing lifestyle is leading to excessive hair problems. Hair loss drugs market targets men more than women, as the problem is more persistent in males. The majorly prescribed hair loss drugs are:
- Finasteride: The Food and Drug Administration approved this drug for treating men with hair loss. The drug is reported to slow down hair loss in 88% of the men and stimulate hair re-growth in about 66% of the men.
- Corticosteroids: If hair loss is due to inflammation then corticosteroid drugs are injected in the scalp. These drugs help in stopping inflammation and are majorly prescribed for patients suffering from alopecia areata.
Prescription Hair Loss and Hair Removal Drugs Market: Segmentation
On the other hand, the hair removal drugs market is majorly focused on females than the male population. All the drugs used for hair removal are either anti-androgens or androgen inhibitors. Androgen is the hormone responsible for excessive hair growth. This market is primarily divided into the following segments:
- Oral contraceptive pills or birth control pills: For women whose hair growth is related to hormonal problems mostly due to aspolycystic ovary syndrome, treatment includes oral contraceptive pills as these pills reduce the level of androgen. The pills which are generally recommended contain ethinylestrodiol (oestrogen) and antiandrogenic progesterone. In addition, these contraceptives also include cyproterone acetate, drospirenone or dienogest.
- Hair removal drugs: Prescription hair removal drug market consists of the following drugs:
- Vaniqa: Vaniqua is the only prescription hair loss medication approved by the Food and Drug Administration that reduces growth of unwanted hair on face and body
- Spironolactone: Spironolactone or aldactone is majorly used to treat excessive body hair in U.S. and is prescribed for patients suffering from hormonal condition hirsutism
- Flutamide: Flutamide is an effective drug used for hampering growth of excess body and facial hair
- Finasteride: Finasteride, also known as Propecia or Proscar, works by blocking the conversion of testosterone into dihydrotestosterone, the hormone responsible for stimulating growth in hair follicles on the body
- Ketoconazole: This is a relatively new drug in the market and is used to control excessive hair growth on the body during hormonal imbalance
A new anti-androgen drug Fluridil has also been developed for treating hyperandrogenic skin syndromes such as hirutism. The clinical study is performed for three months to evaluate the efficacy and safety of 2% fluridil gel in female patients. The results of the study have shown that 2% fluridil gel is an effective and safe method to treat hirsutism.
Prescription Hair Loss and Hair Removal Drugs Market: Geographical Dynamics
The market of North America leads the global market for prescription hair loss and hair removal drugs market followed by the market of Europe due to changing lifestyle and increasing smoking and alcohol consumption leading to hormonal problems in females. According to the Washington Post, hair loss sufferers in America spend more than 3.5 billion dollars a year to treat their hair loss. The market of Asia-Pacific is also growing at a fast pace due to increasing divergence towards the western culture. China is a major revenue generating market for prescription hair loss and hair removal drugs. The major restraint the market is facing currently is the side effects caused by these drugs. Some of the drugs are reported to cause irritation and redness of skin, moods swings and changes in menstrual cycle in some patients.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
- Middle East and Africa (GCC, Southern Africa, North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.